Influence of timing on CSF tests value for Creutzfeldt-Jakob disease diagnosis
- PMID: 17385081
- PMCID: PMC2779401
- DOI: 10.1007/s00415-006-0472-9
Influence of timing on CSF tests value for Creutzfeldt-Jakob disease diagnosis
Abstract
Background: The analysis of markers in the cerebrospinal fluid (CSF) is useful in the diagnosis of sporadic Creutzfeldt-Jakob disease (sCJD). However, the time at which the study of these markers is most sensitive remains controversal.
Objective: To assess the influence of time of sampling on the value of CSF tests in the diagnosis of sCJD.
Method: In the framework of a multinational European study, we studied the results of 14-3-3, S100b, neurone specific enolase (NSE) and tau protein in 833 CSF samples from sCJD patients at different stages of disease and in 66 sequentially repeated lumbar punctures (LP).
Results: 14-3-3 and tau protein tended to increase in sensitivity from onset (88%, 81%) to the advanced stage (91%, 90%). This was significant only in the methionine-valine (MV) heterozygous group of patients at codon 129. The absolute levels of S100b (p < 0.05), NSE and tau protein increased in the last stage of disease. High levels of tau protein, NSE and S100b were associated with shorter survival times (p < 0.01). Sixty-six sCJD patients underwent repeated LP. These sCJD patients were younger, had longer disease durations and were more frequently MV at codon 129 (p < 0.001) than the whole group. 14-3-3 sensitivity increased from 64% to 82% in the second LP (p = 0.025) and 88% sCJD patients had at least one positive result.
Conclusions: Sensitivity and absolute levels of CJD markers increased with disease progression and were modulated by the codon 129 genotype. Early negative results should be inter-preted with caution, especially in young patients or those who are MV at codon 129.
Figures


Similar articles
-
The role of cerebrospinal fluid 14-3-3 and other proteins in the diagnosis of sporadic Creutzfeldt-Jakob disease in the UK: a 10-year review.J Neurol Neurosurg Psychiatry. 2010 Nov;81(11):1243-8. doi: 10.1136/jnnp.2009.197962. Epub 2010 Sep 20. J Neurol Neurosurg Psychiatry. 2010. PMID: 20855493
-
Diagnostic accuracy of cerebrospinal fluid protein markers for sporadic Creutzfeldt-Jakob disease in Canada: a 6-year prospective study.BMC Neurol. 2011 Oct 27;11:133. doi: 10.1186/1471-2377-11-133. BMC Neurol. 2011. PMID: 22032272 Free PMC article.
-
Diagnostic value of CSF protein profile in a Portuguese population of sCJD patients.J Neurol. 2009 Sep;256(9):1540-50. doi: 10.1007/s00415-009-5160-0. Epub 2009 May 6. J Neurol. 2009. PMID: 19418113
-
Cerebrospinal fluid biomarkers in Creutzfeldt-Jakob disease.Clin Neurol Neurosurg. 2005 Aug;107(5):355-60. doi: 10.1016/j.clineuro.2004.12.002. Epub 2005 Jan 12. Clin Neurol Neurosurg. 2005. PMID: 16023527 Review.
-
Clinical findings and diagnostic tests in Creutzfeldt-Jakob disease and variant Creutzfeldt-Jakob disease.Folia Neuropathol. 2004;42 Suppl B:24-38. Folia Neuropathol. 2004. PMID: 16903140 Review.
Cited by
-
Cerebrospinal fluid biomarkers in human genetic transmissible spongiform encephalopathies.J Neurol. 2009 Oct;256(10):1620-8. doi: 10.1007/s00415-009-5163-x. Epub 2009 May 15. J Neurol. 2009. PMID: 19444528 Free PMC article.
-
CSF Ubiquitin Levels Are Higher in Alzheimer's Disease than in Frontotemporal Dementia and Reflect the Molecular Subtype in Prion Disease.Biomolecules. 2020 Mar 25;10(4):497. doi: 10.3390/biom10040497. Biomolecules. 2020. PMID: 32218217 Free PMC article.
-
Diagnostic and prognostic value of human prion detection in cerebrospinal fluid.Ann Neurol. 2017 Jan;81(1):79-92. doi: 10.1002/ana.24833. Ann Neurol. 2017. PMID: 27893164 Free PMC article.
-
Fatal Familial Insomnia: Clinical Aspects and Molecular Alterations.Curr Neurol Neurosci Rep. 2017 Apr;17(4):30. doi: 10.1007/s11910-017-0743-0. Curr Neurol Neurosci Rep. 2017. PMID: 28324299 Review.
-
Isolated CSF RT-QuIC positivity associates with a less aggressive disease course and decreased levels of neuronal/glial damage biomarkers in patients with sporadic Creutzfeldt-Jakob disease.J Neurol. 2025 Feb 11;272(3):198. doi: 10.1007/s00415-024-12757-8. J Neurol. 2025. PMID: 39932589
References
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1159/000017095', 'is_inner': False, 'url': 'https://doi.org/10.1159/000017095'}, {'type': 'PubMed', 'value': '10068257', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/10068257/'}]}
- Beaudry P, Cohen P, Brandel JP, et al. (1999) 14-3-3 protein, neuron-specific enolase, and S100b protein in cerebrospinal fluid of patients with Creutzfeldt- Jakob disease. Dement Geriatr Cogn Disord 10(1):40–6 - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1002/1531-8249(20010201)49:2<257::AID-ANA48>3.0.CO;2-X', 'is_inner': False, 'url': 'https://doi.org/10.1002/1531-8249(20010201)49:2<257::aid-ana48>3.0.co;2-x'}, {'type': 'PubMed', 'value': '11220747', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/11220747/'}]}
- Brandel JP, Peoc’h K, Beaudry P, et al. (2001) 14-3-3 protein cerebrospinal fluid detection in human growth hormone- treated Creutzfeldt-Jakob disease patients. Ann Neurol 49(2):257–60 - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1159/000066174', 'is_inner': False, 'url': 'https://doi.org/10.1159/000066174'}, {'type': 'PubMed', 'value': '12422071', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/12422071/'}]}
- Giraud P, Biacabe A-G, Chazot G, et al. (2002) Increased detection of 14-3-3 protein in Cerebrospinal fluid in Sporadic Creutzfeldt-Jakob disease during the disease course. Eur Neurol 48:218–221 - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1016/S0022-1759(97)00050-1', 'is_inner': False, 'url': 'https://doi.org/10.1016/s0022-1759(97)00050-1'}, {'type': 'PubMed', 'value': '9236913', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/9236913/'}]}
- Green AJE, Keir G, Thompson EJ (1997) A specific and sensitive ELISA for measuring S100b in the cerebrospinal fluid. J Immmunol Methods 205:35–41 - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1016/0009-8981(92)90103-W', 'is_inner': False, 'url': 'https://doi.org/10.1016/0009-8981(92)90103-w'}, {'type': 'PubMed', 'value': '1468153', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/1468153/'}]}
- Jimi T, Wakayama Y, Shibuya S, et al. (1992) High levels of nervous systemspecific proteins in cerebrospinal fluid in patients with early stage Creutzfeldt-Jakob disease. Clin Chim Acta 211:37–46 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous